In a new set of mass tort claims, Horizon Therapeutics is facing scrutiny for their failure to accurately portray the risks of their product Tepezza, a drug used to treat Thyroid Eye Disease.  Tepezza users have experienced complete and permanent hearing loss or tinnitus after receiving treatments. The claims brought against Horizon Therapeutics are being […]

The post Plaintiffs Ask Judge to Appoint Leadership Committee in Tepezza Lawsuits appeared first on Dolman Law Group.